CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 1.99 Delayed Data As of 3:59pm ET |  -0.08 / -3.86%Today’s Change | 1.45 Today|||52-Week Range 10.30 | +11.17% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.07 |
| Today’s open | 2.06 |
| Day’s range | 1.99 - 2.06 |
| Volume | 2,519 |
| Average volume (3 months) | 34,902 |
| Market cap | $21.2M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +38.40% |
| Earnings growth (this year) | +38.89% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +100.12% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 0.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Amexdrug Corp | 0.00 | 0.00% |
| ---- | ||
| ZYNEZynerba Pharmaceutic... | +0.02 | +3.18% |
| LUMOLumos Pharma Inc | +0.03 | +0.85% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 31, 2023 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | -$36.7M |
| Net profit margin | -122.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
